Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Investing Activities (2020 - 2026)

SkinHealth Systems has reported Cash from Investing Activities over the past 6 years, most recently at -$1.4 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 60.32% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2025, up 24.01% year-over-year, with the annual reading at -$5.2 million for FY2025, 24.01% up from the prior year.
  • Cash from Investing Activities was -$1.4 million for Q4 2025 at SkinHealth Systems, down from -$1.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$862000.0 in Q4 2024 and troughed at -$21.7 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$2.5 million (2022), against an average of -$5.0 million.
  • The largest YoY upside for Cash from Investing Activities was 98.15% in 2021 against a maximum downside of 1478.77% in 2021.
  • A 5-year view of Cash from Investing Activities shows it stood at -$8.5 million in 2021, then skyrocketed by 66.89% to -$2.8 million in 2022, then rose by 23.23% to -$2.2 million in 2023, then surged by 60.24% to -$862000.0 in 2024, then plummeted by 60.32% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Cash from Investing Activities are -$1.4 million (Q4 2025), -$1.1 million (Q3 2025), and -$1.6 million (Q2 2025).